Potential Of Microemulsions Research Articles

From Nanotechnology to Oilfields: the Potential of Microemulsions and Nanoemulsions in Preflush Fluids for a Sustainable Alternative

Objective: The objective of this study is to contextualize the advancements in the application of micro- and nanoemulsions in preflush fluids within the oil industry. Theoretical Framework: The study draws upon concepts in nanotechnology and fluid dynamics, focusing on the role of preflush fluids in wellbore cleaning and rock wettability adjustment. Method: A bibliometric analysis and review of the literature were conducted. The bibliometric analysis included 145 keywords and 382 articles related to preflush fluids in the oil industry, published between 2003 and 2023. The data were analyzed and visualized using VOSviewer. Results and Discussion: The results revealed fluctuations in the number of publications on this topic over the years. The bibliometric review highlighted the evolution of preflush fluid formulations, particularly those involving micro- and nanoemulsion systems. These fluids demonstrated high oil solubilization capacity and wettability reversal, effectively addressing formation stability issues. Research Implications: The findings underscore the significance of micro- and nanoemulsion systems in enhancing the efficiency and environmental sustainability of preflush fluids used in oil extraction operations. Originality/Value: This study contributes to the literature by offering a comprehensive analysis of the advancements in preflush fluid formulations, emphasizing the sustainable potential of micro- and nanoemulsions in the oil industry.

Preparation, Characterization, and Skin Permeation Evaluation of Naproxen Microemulsions for Transdermal Delivery

: Microemulsions (MEs) are considered for preparing drug delivery carriers, especially transdermal vehicles. Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used to manage chronic and acute pain and inflammatory diseases. However, NSAIDs have drawbacks such as gastrointestinal tract disorders and poor pharmacokinetic properties for oral administration. To address these issues, we evaluated the potential of ME as a transdermal system for locally delivering naproxen (NPX) as an NSAIDs model (NPX-MEs). Phase diagrams were constructed for MEs composed of tween 80, span 80, and propylene glycol (PG) as surfactant (S)/cosurfactant (CS), transcutol® P (TRC-P), and LabrafacTM PG as oil. The final concentration of NPX in MEs was 1% (w/v). The MEs were analyzed for particle size, refractive index, and viscosity. In vitro permeability studies of NPX-MEs were conducted using Franz diffusion cells on rat skin samples. Additionally, the effects of Eucalyptus oil (EU oil), oleic acid (OLA), and TRC-P as enhancers on the skin permeation of NPX were investigated. The particle size and viscosity values of the NPX-MEs ranged from 7.05 ± 0.03 to 79.56 ± 0.58 nm and 222.4 ± 0.87 to 681.13 ± 1.97, respectively. The optimal formulation, ME-3, consisted of 20% oil, 10% water, and 70% S/C phases. The skin permeation rates of NPX from ME-3 were higher than those of other formulations (Dapp = 1.36 ± 0.616, ERD=527.989 ± 313.627) with a lower lag time. Additionally, OLA-treated skin showed the highest transdermal permeation rate (ERD = 75.55 ± 23.532). Based on these results, the formulated NPX-ME may be a desirable carrier for transdermal delivery compared to traditional formulations, potentially reducing side effects and improving the therapeutic efficacy of NPX.

Exploring the Versatility of Microemulsions in Cutaneous Drug Delivery: Opportunities and Challenges.

Microemulsions are novel drug delivery systems that have garnered significant attention in the pharmaceutical research field. These systems possess several desirable characteristics, such as transparency and thermodynamic stability, which make them suitable for delivering both hydrophilic and hydrophobic drugs. In this comprehensive review, we aim to explore different aspects related to the formulation, characterization, and applications of microemulsions, with a particular emphasis on their potential for cutaneous drug delivery. Microemulsions have shown great promise in overcoming bioavailability concerns and enabling sustained drug delivery. Thus, it is crucial to have a thorough understanding of their formulation and characterization in order to optimize their effectiveness and safety. This review will delve into the different types of microemulsions, their composition, and the factors that affect their stability. Furthermore, the potential of microemulsions as drug delivery systems for skin applications will be discussed. Overall, this review will provide valuable insights into the advantages of microemulsions as drug delivery systems and their potential for improving cutaneous drug delivery.

Biocompatible topical microemulsions – use and perspectives as cutaneous delivery systems for medicines

This review refers to biocompatible microemulsions, which in recent decades have attracted the interest of formulators as nanosystems useful for the skin drug delivery. Microemulsions are homogeneous pseudoternary colloidal dispersions, thermodynamically stable, fluid, transparent, isotropic, consisting of an oil phase and an aqueous phase, stabilized by a mixture of surfactant and cosurfactant and with the droplet diameter of the dispersed phase usually within the range 10-100 nm. To support the potential of biocompatible microemulsions as an innovative topical pharmaceutical form, this paper provides an overview of their type, formulation, structure, composition and characterization, as well as their advantages and disadvantages. Currently, the main purpose of the dermal microemulsion formulation is to obtain optimal drug bioavailability under conditions of minimal skin irritability. Numerous studies carried out in the last two decades have shown the potential of microemulsions to increase the percutaneous penetration of drugs, acting as penetration enhancers due to the following advantageous characteristics: high solubilization capacity of natural and synthetic lipophilic and hydrophilic compounds; the release of a large amount of active ingredient in the skin, followed by an increased dermal distribution and permeation. Ensuring skin tolerance in the presence of large amounts of surfactant and co-surfactant in the formulation of microemulsions can be achieved by selecting clinically accepted excipients for topical preparations and generally recognized as safe (Food and Drug Administration). Therefore, biocompatible dermal microemulsions can be prepared using natural excipients (vegetable oils, non-ionic surfactants, volatile oils), which are biodegradable and have lower skin toxicity and irritant potential than synthetic ones.

Anti-inflammatory potential of microemulsion and pure bullfrog oil in muscle injury

ABSTRACT Introduction: Every day science seeks new ways to treat various diseases through drugs that are efficient and viable. Thus, therapeutic alternatives that meet such demand are targets of study. Microemulsions are one of these new alternatives due to their peculiar pharmacodynamic and pharmacokinetic characteristics. Objective: The aim of this study was to analyze the anti-inflammatory potential of microemulsion and pure bullfrog oil using an experimental model of muscle injury. Methods: Male Swiss mice were divided into three groups: control, microemulsion and pure bullfrog oil. After the pre-treatment, a muscle injury was induced in the animals’ leg and subsequently evaluations were carried out in the horizontal extent of edema and compared between the groups at predetermined times. Following evaluation of muscle injury, dissection of the right gastrocnemius muscles was performed for histological analysis. Results: The microemulsion and pure bullfrog oil showed good anti-inflammatory activity, acting similarly in reducing edema during the first two hours, but without statistical significance from the 3rd to the 24th hour after induction. The histological analysis revealed that the muscle tissue of the animals treated with the microemulsion presented mild cellular infiltrate and little wear of muscle fibers when compared with the muscular tissue of animals treated with the pure bullfrog oil. The histological analysis of the hepatic tissue showed signs of injury in the liver lobes of the pure bullfrog oil group, not observed in the microemulsion group. Conclusion: The microemulsion sho-wed good anti-inflammatory potential in the acute phase of the inflammatory response, reducing the formation of edema and preserving muscle tissue against the occurrence of lesions and without inducing injury in hepatic tissue.

Potential of Microemulsions in Drug Delivery and Therapeutics: A Patent Review

The recent success of cyclosporin marketed formulation--Sandimmune Neoral by Sandoz in Europe has invigorated the gaining interest in microemulsions as potential drug delivery systems. These thermodynamically stable, transparent (or translucent) dispersions of oil and water stabilized by an interfacial film of surfactant molecules have potential applications whenever it is necessary to mix oil and water and where a large oil-water interface is required. Thus, microemulsions have drawn considerable interest. Until now excellent reviews covering aspects of bioavailability, theories, physical properties, formulation design, physical characterization, drug release and delivery potential have been cited in literature but there is no review that discusses the intellectual (patent) aspect of these delivery systems. In order to appreciate the intellectual potential of these delivery systems, this review summarizes the patents governing various applications of these delivery systems.

Relationship between structural features and in vitro release of doxorubicin from biocompatible anionic microemulsion

In this work structural features of anionic microemulsions, containing the pharmaceutical biocompatible components soya phosphatidylcholine (SPC), eumulgin HRE 40 (EU) and sodium oleate (SO) as surfactant, cholesterol (CHO) as oil phase and aqueous buffer were studied. Microemulsions were formulated with and without the antitumor drug doxorubicin (DOX). The various microstructures characterized in the pseudo-ternary phase diagram were analyzed by polarized light microscopy, small-angle X-ray scattering (SAXS) and X-ray diffraction (XRD) as well as by their ability to incorporate and release DOX. The experimental results demonstrated a correlation between the composition, the structural features and drug delivery. It was found that at higher cholesterol contents, the crystallization of CHO polymorph phases changed the mobility of DOX molecules. Droplets were formed with short-range spatial correlation from a microemulsion (ME) with a low surfactant:oil ratio. More ordered structures with lamellar arrangements formed by the increasing of the CHO proportions in the formulation may be due to CHO crystallization. The in vitro release of DOX showed that the presence of a high content of crystalline CHO prolongs the release of DOX from ME. The retention of DOX in the internal oil phase of the ME may modulate the drug release for a prolonged time. These results clearly demonstrate the potential of ME as a drug-delivery system.

Bicontinuous Water-AOT/Tween85-Isopropyl Myristate Microemulsion: A New Vehicle for Transdermal Delivery of Cyclosporin A

ABSTRACTThe purpose of this study was to investigate the influence of structure and composition of microemulsions (AOT/Tween85/isopropyl myristate/water) on their transdermal delivery potential of a lipophilic model drug (Cyclosporin A), and to compare the drug delivery potential of microemulsion to the suspension of drug in normal saline containing 20% ethanol. Their type and structure were examined by measuring surface tension, density, viscometry, and electric conductivity; the degree of agreement between the techniques was assessed. Transdermal flux of Cyclosporin A through rat skin was determined in vitro using Franz-type diffusion cells. Results of conducting, viscosity, and surface tension measurement confirmed the prediction transition to a bicontinuous structure. The microemulsions increased transdermal drug delivery of Cyclosporin A up to 10 times compared to the suspension. The increased transdermal delivery was found to be due mainly to water concentration and appeared to be dependent on the structure of the microemulsions.

Microemulsion-based media as novel drug delivery systems

Microemulsions are clear, stable, isotropic mixtures of oil, water and surfactant, frequently in combination with a cosurfactant. These systems are currently of interest to the pharmaceutical scientist because of their considerable potential to act as drug delivery vehicles by incorporating a wide range of drug molecules. In order to appreciate the potential of microemulsions as delivery vehicles, this review gives an overview of the formation and phase behaviour and characterization of microemulsions. The use of microemulsions and closely related microemulsion-based systems as drug delivery vehicles is reviewed, with particular emphasis being placed on recent developments and future directions.